Report examines ROI on personalized medicine

Personalized medicine--which uses genetic data to provide specialized medicine for individual patients--is slowly moving into the healthcare mainstream, though only a few practical applications exist to date. However, when it does become practical, it may be a financial blessing. A new report by the Deloitte Center for Health Solutions finds that personalized medicine could provide significant ROI for all of the key stakeholders in the U.S. healthcare system. Article

Suggested Articles

Insurer and business groups are ramping up efforts to delay the ACA's insurer tax as a year-end deadline looms.

A group of Senate and House lawmakers are demanding CMS answer for technical issues that may have impacted sign-ups on

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry.